Uncertainty on the use of aldosterone antagonists for primary therapy for sudden cardiac death in the setting of implanted devices

Circulation. 2007 Jun 12;115(23):2983-9; discussion 2989. doi: 10.1161/CIRCULATIONAHA.106.684522.
No abstract available

Publication types

  • Comment
  • Review

MeSH terms

  • Death, Sudden, Cardiac / prevention & control*
  • Defibrillators, Implantable
  • Heart Diseases / therapy
  • Humans
  • Mineralocorticoid Receptor Antagonists / adverse effects
  • Mineralocorticoid Receptor Antagonists / therapeutic use*
  • Myocardial Infarction / therapy

Substances

  • Mineralocorticoid Receptor Antagonists